Japan Medical Gas and Equipment Market Overview,2030

Japan’s medical gas and equipment market has become one of the most advanced and safety-regulated sectors in Asia, reflecting the country’s long-standing focus on precision engineering, patient safety, and hospital modernization. The evolution of medical gas systems began in the 1970s when leading hospitals such as the University of Tokyo Hospital and Osaka University Hospital adopted centralized pipeline networks to replace individual cylinder systems, setting a benchmark for automated gas delivery infrastructure. These systems supply oxygen, nitrogen, nitrous oxide, and medical air through cryogenic storage tanks and manifold systems designed to maintain purity under Japanese Industrial Standards and ISO-certified protocols. The rapid rise in chronic respiratory diseases and a growing elderly population more than 29% of Japan’s citizens are over 65, according to the Ministry of Health, Labour and Welfare has significantly expanded demand for oxygen therapy in both hospitals and home healthcare. Facilities such as St. Luke’s International Hospital in Tokyo and Nagoya University Hospital have installed on-site PSA oxygen generation systems to reduce dependency on external supply chains and improve emergency readiness. Smart monitoring systems integrated with building management software allow real-time tracking of pressure, purity, and flow, ensuring uninterrupted care during high-demand periods such as flu seasons or pandemic surges. Cryogenic storage advancements developed by Japanese engineering firms have further enhanced gas purity and energy efficiency, with newer systems now using automation for alarm control and leak detection. Portable oxygen concentrators have become essential for home-based care, especially in rural prefectures like Hokkaido and Okinawa. Japan’s strict compliance with the Japanese Pharmacopoeia and ISO 7396 ensures consistent quality across gas production, storage, and delivery. Environmental sustainability efforts are also underway, with local producers adopting cylinder recycling programs and energy-efficient air separation technologies to reduce emissions while maintaining Japan’s global reputation for precision, reliability, and innovation in medical gas infrastructure.

According to the research report, ""Japan Medical Gas and Equipment Market Overview, 2030,"" published by Bonafide Research, the Japan Medical Gas and Equipment market is anticipated to add to more than USD 360 Million by 2025–30. The lessons from the COVID-19 crisis accelerated the development of emergency oxygen supply systems, with hospitals like Keio University Hospital and Kobe City Medical Center installing mobile and on-site oxygen plants to ensure continuous ICU operation during surges. Major suppliers such as Taiyo Nippon Sanso, Air Water Inc., and Iwatani Corporation dominate the national landscape, providing oxygen, nitrous oxide, and specialty gas mixtures for hospitals, clinics, and research facilities. Collaborations between Taiyo Nippon Sanso and Hitachi have resulted in smart gas management systems utilizing IoT and AI to optimize gas flow and detect anomalies automatically. Air Water Inc. has expanded its cryogenic production capacity in Osaka and Fukuoka to serve both medical and pharmaceutical clients, integrating advanced purity monitoring to meet growing demand for biotechnology and vaccine manufacturing. The Ministry of Economy, Trade and Industry has funded initiatives under its Smart Hospital Project to promote automation and energy efficiency in gas infrastructure. Startups such as Minato Medical and Fukuda Denshi are introducing compact, portable oxygen devices that enable telemonitored home therapy for elderly patients, aligning with Japan’s nationwide telehealth strategy. Logistics and storage networks have been strengthened through automated cylinder tracking systems and regional micro-generation units to improve supply stability across remote areas and islands. Partnerships between Mitsubishi Chemical Engineering and university research labs are advancing gas applications in regenerative medicine and cryogenic preservation of stem cells.

In Japan the market for medical gases and equipment is characterised by two closely integrated segments encompassing the supply of gases and the hardware to deliver them effectively. On the medical gases side leading Japanese firms such as Taiyo Nippon Sanso Corporation and Nippon Sanso Holdings Corporation distribute medical-grade oxygen, medical air, nitrous oxide, nitrogen and carbon dioxide to hospitals in Tokyo, Osaka and Sapporo as well as to home‐care providers across rural prefectures. On the medical gas equipment side Japanese manufacturers supply a wide array of devices including cylinder regulators, manifold banks, bed-head terminal units, flowmeters, vacuum and suction systems and full on-site gas generation plants that are installed in major facilities such as the St. Luke’s International Hospital in Tokyo and the Osaka University Hospital in Osaka. Equipment providers in Japan often deliver integrated pipeline systems and automated gas-switching modules that meet the standards of Japan’s Ministry of Health, Labour and Welfare, while gas suppliers ensure high-purity gases are compatible with delivery hardware for critical-care and surgical environments. Smaller clinics and home-care users utilise portable concentrators and cylinder banks, particularly in remote islands like Okinawa or mountainous prefectures like Nagano, where logistics favour modular equipment rather than large central plants. The coordination between gas supply and physical delivery equipment is vital in Japan’s healthcare infrastructure because the ageing population demands reliable and efficient systems and because domestic firms emphasise high-quality engineering and safety compliance in both segments.

In Japan the applications for medical gases and equipment span therapeutic treatment, diagnostic procedures, pharmaceutical manufacture and a range of other specialised uses within the healthcare ecosystem. Therapeutically hospitals such as the National Hospital Organization Tokyo Medical Center and regional facilities in Hokkaido deploy oxygen therapy and medical-air systems to support patients with chronic respiratory illnesses and post-operative recovery in intensive-care units, while home-care services facilitate domiciliary oxygen delivery. In diagnostic contexts hospitals in Kyoto and Fukuoka use carbon dioxide for laparoscopic insufflation during minimally invasive surgeries, helium in MRI magnet cooling systems and calibration-gas mixtures in biomedical laboratories. Within the pharmaceutical industry manufacturing sites in Kanagawa and Shizuoka produce sterile pharmaceuticals and biologicals using high-purity nitrogen and oxygen along with specialised delivery infrastructure meeting GMP standards. Other applications include nitrous oxide analgesia in dental practices throughout Japan, vacuum and suction systems in mobile emergency response units in rural Tohoku municipalities and portable manifold systems serving disaster-relief field hospitals following seismic events. The regulatory environment administered by Japanese health authorities governs gas purity, equipment calibration and delivery protocols across these applications which collectively support clinical, diagnostic and manufacturing operations throughout Japan’s healthcare and life-science sectors.

In Japan the end-users of medical gases and related equipment include hospitals, home healthcare providers, ambulatory surgical centres, pharmaceutical and biotechnology companies, and academic and research institutions, each with unique infrastructure demands. Major tertiary hospitals in metropolitan areas such as Tokyo and Yokohama maintain on-site gas production plants, manifold systems, piped oxygen and vacuum networks servicing operating rooms and intensive-care units. Home‐healthcare providers across Japan supply portable oxygen concentrators, cylinder systems and flow-control regulators to patients living in remote prefectures such as Shimane or on outlying islands like the Ogasawara archipelago, supported by regional health programmes. Ambulatory surgical centres located in cities such as Nagoya and Hiroshima utilise compact gas delivery units and cylinder banks to facilitate day-surgery, sedation and outpatient procedures. Pharmaceutical and biotechnology firms operating in hubs like Tsukuba and Kobe install ultra-high-purity gas systems and precision equipment for drug development, formulation and analytic laboratories under rigorous Japanese regulatory frameworks. Academic and research institutions such as the University of Tokyo Hospital and institutes affiliated with Kyoto University maintain bespoke pipeline installations, controlled gas‐storage facilities and specialised equipment to support translational research and teaching hospitals. Each of these user categories in Japan reflects a distinct procurement, maintenance and regulatory approach for medical gases and equipment within the broader national healthcare infrastructure. 

Considered in this report
• Historic Year: 2019
• Base year: 2024
• Estimated year: 2025
• Forecast year: 2030

Aspects covered in this report
• Medical Gas and Equipment Market with its value and forecast along with its segments
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

By Product Type
• Medical Gases
• Medical Gas Equipment

By Application
• Therapeutic
• Diagnostic
• Pharmaceutical Industry
• Others

By End-User
• Hospitals
• Home Healthcare
• Ambulatory Surgical Centers
• Pharmaceutical & Biotechnology Companies
• Academic & Research Institutions Show more